Bevacizumab in combination with irinotecan plus fluorouracil plus leucovorin chemotherapy prolongs survival but increases adverse events in people with metastatic colorectal cancer

Michael A. Choti

Research output: Contribution to journalArticle

6 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)715-720
Number of pages6
JournalCancer Treatment Reviews
Volume30
Issue number8
DOIs
StatePublished - Dec 2004

Fingerprint

irinotecan
Leucovorin
Fluorouracil
Colorectal Neoplasms
Drug Therapy
Bevacizumab

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

@article{2b6f8bed5b0f4046840072b633e7b0a7,
title = "Bevacizumab in combination with irinotecan plus fluorouracil plus leucovorin chemotherapy prolongs survival but increases adverse events in people with metastatic colorectal cancer",
author = "Choti, {Michael A.}",
year = "2004",
month = "12",
doi = "10.1016/j.ctrv.2004.09.003",
language = "English (US)",
volume = "30",
pages = "715--720",
journal = "Cancer Treatment Reviews",
issn = "0305-7372",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Bevacizumab in combination with irinotecan plus fluorouracil plus leucovorin chemotherapy prolongs survival but increases adverse events in people with metastatic colorectal cancer

AU - Choti, Michael A.

PY - 2004/12

Y1 - 2004/12

UR - http://www.scopus.com/inward/record.url?scp=8644249844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8644249844&partnerID=8YFLogxK

U2 - 10.1016/j.ctrv.2004.09.003

DO - 10.1016/j.ctrv.2004.09.003

M3 - Article

C2 - 15541582

AN - SCOPUS:8644249844

VL - 30

SP - 715

EP - 720

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

SN - 0305-7372

IS - 8

ER -